81例喉癌疗效分析  

Treatment of Laryngeal Carcinoma: A Report of 81 Cases

作　　者：李文竹[1] 张玉书[1] 

机构地区：[1]首都医科大学附属北京友谊医院放疗科

出　　处：《首都医科大学学报》2000年第2期152-154,共3页Journal of Capital Medical University

摘　　要：为研究单纯放疗及综合治疗对喉癌预后的影响 ,对 81例喉癌患者进行了分析。发现 :单纯放疗组和综合治疗组 (手术 +放疗 )的 5年生存率分别为 51 .6% ( 32 /62 )及 84 .2 % ( 1 6/1 9) ,其中Ⅰ、Ⅱ期喉癌单纯放疗组的 5年生存率为 85% ( 1 7/2 0 ) ,略高于综合治疗组的 50 % ( 1 /2 ) (P >0 .0 5) ,Ⅲ、Ⅳ期喉癌综合治疗组的 5年生存率为 88.2 %( 1 5/1 7) ,显著高于单纯放疗组的 35.7% ( 1 5/4 2 ) (P <0 .0 5)。提示喉癌病例Ⅰ、Ⅱ期应首选放疗方案 ,Ⅲ、Ⅳ期以综合治疗为佳。To investigate the results of laryngeal carcinoma, 81patients with laryngeal carcinoma treated from Jan.1980 to Jan.1990 received either radiotherapy (R group,62) or surgery plus radiotherapy (S+R group,19).The 5 year survival rates were 51.6%(32/62) and 84.2%(16/19). The 5 year survival rates of stage Ⅰto Ⅱ were 85% (17/20)and 50%(1/2), respectively ( P >0.05). The 5 year survival rates of stage Ⅲ to Ⅳ were 35.7(15/42)and 88.2%(15/17)( P <0.05). It was concluded that for early lesions (stage Ⅰ and Ⅱ)of laryngeal carcinoma, radiotherapy are primary used. For advanced lesions (stage Ⅲ and Ⅳ) of laryngeal carcinoma, combined radiotherapy and surgery are preferred.

关 键 词：喉癌 综合治疗 放射疗法 病例分析 疗效 

分 类 号：R739.650.5[医药卫生—肿瘤]